MedPath

MonoMax for Abdominal Wall Closure

Completed
Conditions
Abdominal Wall Wound
Interventions
Device: MonoMax
Registration Number
NCT01901068
Lead Sponsor
Aesculap AG
Brief Summary

A great number of different suture techniques and suture materials are in use in order to reconstitute the abdominal wall integrity, but there is no surgical gold standard for abdominal wall closure until today. Various Meta-Analyses and randomized controlled trials have been performed, which compared non-absorbable or long-term absorbable versus rapid absorbable suture materials or monofilament versus multifilament suture materials, or continuous versus interrupted suture techniques respectively. This lack of evidence has the following outcome: burst abdomen is observed in 1-3% of patients within the first days after a laparotomy. The incidence of abdominal wall hernias 12 months postoperatively is estimated to be up to 20% (range 9 to 20%) . Wound infections develop in 3 to 21% of patients undergoing a median laparotomy within the first 30 days. At present most surgeons favour monofilament long-absorbable continuous sutures as the most suitable material for closing abdominal wounds after midline laparotomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Age 18 years and older
  • Elective primary laparotomy
  • Written informed consent
Exclusion Criteria
  • Peritonitis
  • Emergency surgery
  • Severe psychiatric and neurologic disease
  • Drug- and / or alcohol abuse according to local standard
  • Lack of informed consent
  • Current immunosuppressive therapy
  • Chemotherapy within the 2 weeks before operation
  • Radiotherapy of the abdomen completed less than 8 before surgery
  • Pregnant or breast-feeding women
  • Coagulopathy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
MonoMaxMonoMaxElective primary laparotomy
Primary Outcome Measures
NameTimeMethod
Frequency of reoperation due to burst abdomenparticipants will be followed for the duration of hospital stay, an expected average of 10 days
Frequency of wound infectionsparticipants will be followed for the duration of hospital stay, an expected average of 10 days
Secondary Outcome Measures
NameTimeMethod
Incidence of wound healing until day of dischargeparticipants will be followed for the duration of hospital stay, an expected average of 10 days
Length of hospital stayparticipants will be followed for the duration of hospital stay, an expected average of 10 days

Trial Locations

Locations (2)

Chirurgicka klinika, Fakultni nemocnine

🇨🇿

Olomouc, Czechia

Central Emergency Military Hospital

🇷🇴

Bucharest, Romania

© Copyright 2025. All Rights Reserved by MedPath